SCHEMBL17485950

SCHEMBL17485950

NC(=O)OCc1ccc(COC=O)o1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.33
NQO1 P15559 1/20 0.33
HPGD P15428 1/20 0.33
ALOX5 P09917 2/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
PKM P14618 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SRC P12931 1/20 0.31
LMNA P02545 2/20 0.31
ALDH1A1 P00352 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
TSHR P16473 1/20 0.31
MAPT P10636 2/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
POLB P06746 2/20 0.30
TDP1 Q9NUW8 2/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9123636 0.87 NQO1 (0.40) SMN1; SMN2NQO1HPGDALOX5CYP1A2
SCHEMBL2540847 0.83 ALDH1A1 (0.35) SMN1; SMN2SRCALDH1A1KMT2ATSHR
SCHEMBL29141709 0.80 TDP1 (0.46) SMN1; SMN2NQO1HPGDALOX5CYP1A2
SCHEMBL4898922 0.79 ALDH1A1 (0.55) SMN1; SMN2NQO1HPGDLMNAALDH1A1
SCHEMBL17485847 0.79 ALDH1A1 (0.51) SMN1; SMN2NQO1HPGDALOX5CYP1A2
SCHEMBL2544210 0.78 ALDH1A1 (0.52) SMN1; SMN2HPGDCYP1A2SRCALDH1A1
SCHEMBL19248471 0.77 CA2 (0.38) SMN1; SMN2SRCKMT2AMAPTNPC1
SCHEMBL17485838 0.76 SMN1; SMN2 (0.42) SMN1; SMN2HPGDALOX5CYP1A2LMNA
SCHEMBL16358205 0.75 ALOX5 (0.53) SMN1; SMN2HPGDALOX5PKMALDH1A1
SCHEMBL18460760 0.75 SMN1; SMN2 (0.35) SMN1; SMN2NQO1HPGDALOX5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170029395-A1 SYNTHESIS OF DERIVATIVES OF DICARBAMATES FROM REDUCTION PRODUCTS OF 2-HYDROXYMETHYL-5-FURUFURAL (HMF) ARCHER DANIELS MIDLAND COMPANY 2017-02-02 US disclosed
US-9487537-B2 Synthesis of isohexide dicarbamates and derivatives thereof ARCHER DANIELS MIDLAND CO. (US) 2016-11-08 US disclosed
US-20160031842-A1 SYNTHESIS OF ISOHEXIDE DICARBAMATES AND DERIVATIVES THEREOF ARCHER DANIELS MIDLAND CO (US) 2016-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160031842-A1 SYNTHESIS OF ISOHEXIDE DICARBAMATES AND DERIVATIVES THEREOF DCK, MCCC2, PRKAA1 SMN1; SMN2 4288/4885NQO1 3325/4885HPGD 344/4885
US-20170029395-A1 SYNTHESIS OF DERIVATIVES OF DICARBAMATES FROM REDUCTION PRODUCTS OF 2-HYDROXYMETHYL-5-FURUFURAL (HMF) MGMT, TKFC, DMPK SMN1; SMN2 3890/4885NQO1 1735/4885HPGD 212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.